Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Trending

Black seed cut fasting blood glucose by 21 mg/dL in a meta-analysis of 16 diabetes trials — but had no effect on insulin, triglycerides, or body weight.

This is the strongest evidence yet that black cumin can meaningfully lower blood sugar in people with type 2 diabetes, but the benefit stops there — it didn't budge other key markers like insulin or weight, so it's not a metabolic cure-all.

A meta-analysis pooling 16 randomized trials found that black seed (Nigella sativa) supplementation lowered fasting blood glucose by an average of 21 mg/dL in people with type 2 diabetes. However, the same analysis showed no significant effect on insulin levels, triglycerides, body weight, or kidney function — meaning the benefit is real but narrow, and likely works through mechanisms other than improving insulin sensitivity or weight loss.

Where this fits in the evidence

Pillser has synthesized 7 studies on Black Cumin for Reduced Fasting Blood Glucose Levels — overall evidence strength: High.

Across 7 studies (6 meta-analyses and 1 systematic review), 6 reported beneficial effects on fasting blood glucose, with effect sizes ranging from small to large (mixed). The evidence is strongest for adults with type 2 diabetes or metabolic syndrome. Doses ranged from 200 to 4600 mg/day, but no clear optimal dose emerged.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top